Gofus Jan, Cerny Stepan, Shahin Youssef, Sorm Zdenek, Vobornik Martin, Smolak Petr, Sethi Ananya, Marcinov Samuel, Karalko Mikita, Chek James, Harrer Jan, Vojacek Jan, Pojar Marek
Department of Cardiac Surgery, Faculty of Medicine and University Hospital in Hradec Králové, Charles University, Hradec Králové, Czechia.
Front Cardiovasc Med. 2022 Aug 30;9:943076. doi: 10.3389/fcvm.2022.943076. eCollection 2022.
Robotic assistance (RA) in the harvesting of internal thoracic artery during minimally invasive direct coronary artery bypass grafting (MIDCAB) provides several potential benefits for surgeon and patient in comparison with conventional MIDCAB. The two technical options have not been thoroughly compared in the literature yet. We aimed to perform this in our cohort with the use of propensity-score matching (PSM).
This was a retrospective comparison of all consecutive patients undergoing conventional MIDCAB (2005-2021) and RA-MIDCAB (2018-2021) at our institution with the use of PSM with 27 preoperative covariates.
Throughout the study period 603 patients underwent conventional and 132 patients underwent RA-MIDCAB. One hundred and thirty matched pairs were selected for further comparison. PSM successfully eliminated all preoperative differences. Patients after RA-MIDCAB had lower 24 h blood loss post-operatively (300 vs. 450 ml, = 0.002). They had shorter artificial ventilation time (6 vs. 7 h, = 0.018) and hospital stay (6 vs. 8 days, < 0.001). There was no difference in the risk of perioperative complications, short-term and mid-term mortality between the groups.
RA-MIDCAB is an attractive alternative to conventional MIDCAB. It is associated with lower post-operative blood loss and potentially faster rehabilitation after surgery. The mortality and the risk of perioperative complications are comparable among the groups.
与传统的微创直接冠状动脉旁路移植术(MIDCAB)相比,在MIDCAB中使用机器人辅助(RA)采集胸廓内动脉对外科医生和患者有若干潜在益处。这两种技术方案在文献中尚未得到充分比较。我们旨在通过倾向评分匹配(PSM)在我们的队列中进行此项比较。
这是一项对在我们机构接受传统MIDCAB(2005 - 2021年)和RA - MIDCAB(2018 - 2021年)的所有连续患者进行的回顾性比较,使用PSM并纳入27个术前协变量。
在整个研究期间,603例患者接受了传统MIDCAB,132例患者接受了RA - MIDCAB。选择了130对匹配病例进行进一步比较。PSM成功消除了所有术前差异。RA - MIDCAB术后患者术后24小时失血量更低(300 vs. 450 ml,P = 0.002)。他们的人工通气时间更短(6 vs. 7小时,P = 0.018),住院时间更短(6 vs. 8天,P < 0.001)。两组之间围手术期并发症风险、短期和中期死亡率无差异。
RA - MIDCAB是传统MIDCAB的一个有吸引力的替代方案。它与术后较低的失血量以及术后可能更快的康复相关。两组之间的死亡率和围手术期并发症风险相当。